Danaher Corporation logo
Danaher Corporation (DHR)
Compare

DHR Balance Sheet

Assets, liabilities, and equity analysis

DHR Quarterly Balance Sheet (USD)

Quarterly ReportTTM
03/27/2026
12/31/2025
09/26/2025
06/27/2025
03/28/2025
12/31/2024
09/27/2024
06/28/2024
Total Current Assets
13.935B13.935B12.756B9.606B10.999B9.525B9.497B10.060B9.609B
5.701B5.701B4.615B1.528B2.957B1.993B2.078B2.627B2.374B
Short-Term Investments
0.000.000.000.000.000.000.000.000.00
Cash & Short-Term Investments
5.701B5.701B4.615B1.528B2.957B1.993B2.078B2.627B2.374B
3.819B3.819B3.913B3.755B4.516B4.314B4.390B3.507B3.298B
2.608B2.608B2.489B2.674B2.689B2.532B2.330B2.678B2.671B
Total Assets
83.544B83.544B83.464B79.897B81.620B79.116B77.542B80.615B78.555B
5.468B5.468B5.531B5.376B6.409B6.210B6.074B6.043B5.743B
42.765B42.765B43.151B42.948B42.991B41.657B40.497B42.173B40.805B
Intangible Assets
17.166B17.166B17.817B18.097B18.629B18.885B18.568B19.854B19.545B
Long-Term Investments
0.000.000.001.529B1.484B1.800B1.815B1.702B1.976B
Total Current Liabilities
7.460B7.460B6.807B6.324B6.792B6.645B6.798B7.339B6.701B
1.790B1.790B1.844B1.698B1.725B1.722B1.753B1.596B1.645B
923.000M923.000M2.000M23.000M1.702B1.601B678.000M2.500B1.901B
Total Liabilities
30.595B30.595B30.930B28.826B29.278B28.259B27.992B29.310B28.653B
17.561B17.561B18.416B16.833B16.853B15.976B15.500B16.324B16.309B
18.484B18.484B18.418B16.856B18.555B17.577B17.146B18.824B18.210B
Net Debt (Cash)
12.783B12.783B13.803B15.328B15.598B15.584B15.068B16.197B15.836B
Total Shareholders' Equity
52.949B52.949B52.534B51.071B52.334B50.849B49.543B51.299B49.897B
Common Stock
9.000M9.000M9.000M9.000M9.000M9.000M9.000M9.000M9.000M
47.637B47.637B46.891B45.920B45.239B44.913B44.188B43.296B42.673B
1.871.871.871.521.621.431.401.371.43
0.350.350.350.330.350.350.350.370.36

DHR Annual Balance Sheet (USD)

Annual Report
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Total Current Assets
12.756B9.497B13.937B15.883B11.648B13.802B25.597B7.094B
4.615B2.078B5.864B5.995B2.586B6.035B19.912B787.800M
Short-Term Investments
0.000.000.000.000.000.000.000.00
Cash & Short-Term Investments
4.615B2.078B5.864B5.995B2.586B6.035B19.912B787.800M
3.913B4.390B4.637B5.064B5.443B4.810B3.268B3.112B
2.489B2.330B2.594B2.765B2.767B2.292B1.628B1.631B
Total Assets
83.464B77.542B84.488B84.350B83.184B76.161B62.082B47.833B
5.531B6.074B5.605B4.593B4.831B4.204B3.066B2.250B
43.151B40.497B41.608B37.276B41.184B35.420B22.712B22.581B
Intangible Assets
17.817B18.568B20.746B19.821B22.843B21.282B9.750B10.283B
Long-Term Investments
0.001.815B1.696B2.164B1.320B27.000M33.700M38.300M
Total Current Liabilities
6.807B6.798B8.274B8.389B8.140B7.402B4.932B4.841B
1.844B1.753B1.766B1.856B2.569B2.049B1.514B1.495B
2.000M505.000M1.875B758.000M215.000M200.000M370.200M51.800M
Total Liabilities
30.930B27.992B30.998B34.260B38.007B36.384B31.800B19.606B
18.416B15.500B16.707B19.086B22.168B21.193B21.517B9.688B
18.418B17.146B19.536B20.616B23.272B22.178B22.526B9.740B
Net Debt (Cash)
13.803B15.068B13.672B14.621B20.686B16.143B2.614B8.953B
Total Shareholders' Equity
52.534B49.543B53.486B50.082B45.167B39.766B30.271B28.214B
Common Stock
9.000M9.000M9.000M9.000M9.000M9.000M8.400M8.200M
46.891B44.188B41.074B39.205B32.827B27.159B24.166B25.163B
1.871.401.681.891.431.865.191.47
0.350.350.370.410.520.560.740.35

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About Danaher Corporation

Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.

Washington, DC
61,000 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Rainer Blair